NCT06058182 (RNAacs) is a clinical trial of blood draws in Coronary Syndrome, sponsored by IRCCS Policlinico S. Donato.

Who is sponsoring NCT06058182?

NCT06058182 is sponsored by IRCCS Policlinico S. Donato.

What drugs are being tested in NCT06058182?

Interventions in NCT06058182: blood draws.

What condition does NCT06058182 study?

NCT06058182 studies Coronary Syndrome.

Is NCT06058182 still recruiting?

NCT06058182 is currently recruiting now. Last updated 6 October 2023.

Last reviewed 2023-10-06 · How we verify

NCT06058182: RNAacs

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RNA as Prognostic Biomarkers in Patients With Acute Coronary Syndrome

Recruiting now Last updated 6 October 2023

What this trial tests

trial testing blood draws in Coronary Syndrome in 70 participants. Currently enrolling.

Timeline

13 July 2020

Primary endpoint
30 January 2026

30 January 2027

Quick facts

Lead sponsor	IRCCS Policlinico S. Donato
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	70
Start date	13 July 2020
Primary completion	30 January 2026
Estimated completion	30 January 2027
Sites	1 location across Italy

Drugs / interventions tested

blood draws — full drug profile →

Conditions studied

Coronary Syndrome — all drugs for Coronary Syndrome →

Sponsor

IRCCS Policlinico S. Donato

Who can join

18 and older, any sex, with Coronary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Identify circulating protein-coding (mRNAs) or non-coding (ncRNAs) transcripts (ACS\_signature) predictive of ventricular dysfunction in ACS patients undergoing PCI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of blood draws

Trials testing the same drug.

NCT06016699 — Immunological Function After Radiation With Either Proton or Photon Therapy · unknown
NCT02241187 — Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resect · NA · completed
NCT00361517 — To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early · Phase 3 · completed

Other recruiting trials for Coronary Syndrome

Currently open trials in the same condition.

NCT07049302 — Comparison of Conventional and Non-Conventional CRF and Their Association With Acute Coronary Syndrome · active not recruiting
NCT06528821 — AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS · active not recruiting
NCT05476991 — Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atheros · Phase 3 · recruiting
NCT06561815 — Body Composition Estimated by Bioelectrical Impedance Analysis in Patients with Acute Coronary Syndrome. · recruiting
NCT05600088 — Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With (N)STEMI or Unstable Angina · NA · active not recruiting

Other IRCCS Policlinico S. Donato trials

Trials by the same sponsor.

NCT07295522 — Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? · Phase 4 · not yet recruiting
NCT07169669 — Multicentre Longitudinal Study of Bone Mineralisation Characteristics in Marfan Syndrome and Ehlers-Danlos Syndrome · not yet recruiting
NCT07455292 — Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging · NA · recruiting
NCT07402161 — The Signature of Alzheimer's Disease in Subjective Cognitive Decline · recruiting
NCT06294119 — Multivariate Approach to the Numerical Assessment of Cortical - Autonomic - VAscular Dynamic Interplay · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06058182 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRCCS Policlinico S. Donato
Last refreshed: 6 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06058182.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing